Answers are grounded in this paper and cite their sources.
HBV exists in the liver of healthy HBcAb(+) individuals, but not in the blood. Therefore, HBV is thought to be transmitted to recipients by liver grafts from the HBcAb(+) donors at a significantly high rate. The prevention of viral activation and clinical disease development by means of passive immunization with HBIG seems promising, although the follow-up period in our study may be too short for any definitive conclusions.
No takes yet. Share an insight, caveat, or question.
Üemoto et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: